Related Experiment Video
Updated: Jun 28, 2025
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.2K
Proteomic Analyses Reveal the Role of Alpha-2-Macroglobulin in Canine Osteosarcoma Cell Migration
Sylwia S Wilk1, Katarzyna Michalak2, Ewelina P Owczarek1,3
1Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-787 Warsaw, Poland.
International Journal of Molecular Sciences
|April 13, 2024
Summary
Researchers identified eight proteins in canine osteosarcoma (OSA) cell lines. Alpha-2 macroglobulin (A2M) was found to inhibit OSA cell migration, suggesting its potential as an anti-metastatic agent.
Area of Science:
- Molecular oncology
- Proteomics
- Canine cancer research
Background:
- Canine osteosarcoma (OSA) is an aggressive bone cancer with a high risk of metastasis, which is the primary cause of death.
- Current treatments for metastatic OSA are lacking, highlighting the need for novel therapeutic targets.
- Proteomic analyses are crucial for identifying key proteins involved in tumor progression and metastasis.
Purpose of the Study:
- To identify differentially expressed proteins in canine OSA cell lines with varying malignancy phenotypes compared to normal canine osteoblasts.
- To evaluate the migratory capacity of canine OSA cell lines and correlate it with their malignancy.
- To investigate the role of identified proteins, particularly alpha-2 macroglobulin (A2M), in canine OSA metastasis.
Main Methods:
- Proteomic analysis using matrix-assisted laser desorption/ionisation-time of flight mass spectrometry (MALDI-TOF/TOF MS) to compare protein expression in OSA cell lines (OSCA-8, OSCA-32) and canine osteoblasts (CnOb).
- Simple Western technique to confirm protein expression levels, specifically for A2M.
- Wound-healing assay to assess the effect of A2M on canine OSA cell migration.
Main Results:
- Eight proteins were significantly differentially expressed (p ≤ 0.05) between canine OSA cell lines and osteoblasts.
- Alpha-2 macroglobulin (A2M) expression was confirmed to be high in normal osteoblasts and lower in OSA cell lines.
- Treatment with A2M significantly inhibited canine OSA cell migration in vitro, suggesting an anti-metastatic role.
Conclusions:
- This study identified several differentially expressed proteins in canine OSA, with A2M showing a potential role in regulating cancer cell migration.
- The findings suggest that A2M may act as an anti-metastatic agent in canine osteosarcoma.
- Further in vitro and in vivo investigations are warranted to validate A2M's therapeutic potential against OSA metastasis.
